Evidence map›Paper›PMID 36145638›Full record

ArticlePharmaceutics2022

Mesoporous Bioactive Glasses Incorporated into an Injectable Thermosensitive Hydrogel for Sustained Co-Release of Sr

Carlotta Pontremoli, Monica Boffito, Rossella Laurano, Giorgio Iviglia, Elisa Torre, Clara Cassinelli, Marco Morra, Gianluca Ciardelli, Chiara Vitale-Brovarone, Sonia Fiorilli

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Development of DipeptidePharmaceutics · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Carlotta PontremoliDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.
Monica BoffitoDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0001-7637-2001
Rossella LauranoDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0003-3018-603X
Giorgio IvigliaNobil Bio Ricerche Srl, Via Valcastellana 26, 14037 Portacomaro, Italy.ORCID 0000-0003-1978-6501
Elisa TorreNobil Bio Ricerche Srl, Via Valcastellana 26, 14037 Portacomaro, Italy.ORCID 0000-0003-3878-2274
Clara CassinelliNobil Bio Ricerche Srl, Via Valcastellana 26, 14037 Portacomaro, Italy.
Marco MorraNobil Bio Ricerche Srl, Via Valcastellana 26, 14037 Portacomaro, Italy.
Gianluca CiardelliDepartment of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.ORCID 0000-0003-0199-1427
Chiara Vitale-BrovaroneDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.
Sonia FiorilliDepartment of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.
Politecnico di Torino · IT

Funding

H2020-NMP-PILOTS-2015 685872
6 · The paper itself

Abstract

An injectable delivery platform for promoting delayed bone healing has been developed by combining a thermosensitive polyurethane-based hydrogel with strontium-substituted mesoporous bioactive glasses (MBG_Sr) for the long-term and localized co-delivery of pro-osteogenic Sr

Indexed as

co-releasedelayed bone regenerationinjectable hydrogelsmesoporous bioactive glassesN-acetylcysteinestrontium ions

Identifiers

PMID36145638
PMCPMC9504849
OpenAlexW4295007510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.